Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Condition(s):Endometrial Serous Adenocarcinoma; Uterine Corpus CarcinosarcomaLast Updated:January 10, 2024Recruiting